News
Pharma giant Eli Lilly’s weight loss drug Mounjaro is priced between Rs. 10,000- ₹15,000 in India making it inaccessible to a ...
As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing ...
Online weight-loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy as the U.S.
Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk's Wegovy ...
"The changes are made in light of the recent market challenges Novo Nordisk has been facing, and the development of the ...
Indian drug cos are increasing their presence in the insulin market. They are competing with multinational corporations.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results